|
ZNF746 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.98020000397037E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.40740000554152E-08 |
| Normal-vs-Stage2 |
3.398100E-02 |
| Normal-vs-Stage3 |
9.91900000000268E-05 |
| Normal-vs-Stage4 |
1.962590E-04 |
| Stage1-vs-Stage2 |
2.761000E-01 |
| Stage1-vs-Stage3 |
5.900600E-01 |
| Stage1-vs-Stage4 |
9.946600E-01 |
| Stage2-vs-Stage3 |
5.362800E-01 |
| Stage2-vs-Stage4 |
3.838400E-01 |
| Stage3-vs-Stage4 |
6.896400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.7458999997736E-07 |
| Normal-vs-AfricanAmerican |
4.53600000005494E-06 |
| Normal-vs-Asian |
8.642700E-03 |
| Caucasian-vs-AfricanAmerican |
1.359680E-02 |
| Caucasian-vs-Asian |
6.825300E-04 |
| AfricanAmerican-vs-Asian |
1.108160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.14239999999366E-05 |
| Normal-vs-Female |
3.81209952493577E-10 |
| Male-vs-Female |
2.138000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.897930E-02 |
| Normal-vs-Age(41-60Yrs) |
1.03340000001673E-07 |
| Normal-vs-Age(61-80Yrs) |
2.91699999999118E-06 |
| Normal-vs-Age(81-100Yrs) |
7.633800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.225000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.017800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.489200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.237800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.146800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.250400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.719900E-03 |
| Normal-vs-Grade 2 |
6.45730000026212E-07 |
| Normal-vs-Grade 3 |
3.82669999999807E-05 |
| Normal-vs-Grade 4 |
1.89878999999893E-05 |
| Grade 1-vs-Grade 2 |
7.671600E-02 |
| Grade 1-vs-Grade 3 |
4.247900E-02 |
| Grade 1-vs-Grade 4 |
2.959000E-01 |
| Grade 2-vs-Grade 3 |
4.822000E-01 |
| Grade 2-vs-Grade 4 |
2.400400E-01 |
| Grade 3-vs-Grade 4 |
9.752300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.202340E-04 |
| Normal-vs-ccB subtype |
6.7681000004427E-07 |
| ccA subtype-vs-ccB subtype |
6.296500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.36890000019308E-07 |
| Normal-vs-N1 |
7.718100E-02 |
| N0-vs-N1 |
7.915600E-01 |
|
|
